Genfit S.A. (GNFTF)
OTCMKTS · Delayed Price · Currency is USD
3.720
+0.440 (13.41%)
At close: Jul 25, 2025
Genfit Revenue
Genfit had revenue of 35.54M EUR in the half year ending June 30, 2025, with 135.16% growth. This brings the company's revenue in the last twelve months to 45.13M, down -43.93% year-over-year. In the year 2024, Genfit had annual revenue of 70.69M with 105.01% growth.
Revenue (ttm)
45.13M EUR
Revenue Growth
-43.93%
P/S Ratio
4.08
Revenue / Employee
250.69K EUR
Employees
180
Market Cap
216.05M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 70.69M | 36.21M | 105.01% |
| Dec 31, 2023 | 34.48M | 8.24M | 31.38% |
| Dec 31, 2022 | 26.25M | -59.11M | -69.25% |
| Dec 31, 2021 | 85.36M | 76.67M | 883.14% |
| Dec 31, 2020 | 8.68M | -30.29M | -77.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| QT Imaging Holdings | 8.26M |
| Northwest Biotherapeutics | 1.09M |
Genfit News
- 17 days ago - Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero - Seeking Alpha
- 4 weeks ago - Genfit (GNFT): HC Wainwright & Co. Lowers Price Target To $7.00 | GNFT Stock News - GuruFocus
- 4 weeks ago - Genfit (GNFTF) Reports 41.7% Revenue Decline in First Half of 2025 - GuruFocus
- 4 weeks ago - Genfit S.A. GAAP EPS of -€0.20, revenue of €35.67M - Seeking Alpha
- 4 weeks ago - GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Earnings Scheduled For September 22, 2025 - Benzinga
- 5 weeks ago - GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD - GlobeNewsWire
- 3 months ago - Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire